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• AVP is a nonapeptide composed of a six-member disulfide ring and a tripeptide 
tail….  
 
• It is synthesized via a polypeptide precursor that includes AVP, neurophysin, 
and co-peptin, all encoded by a single gene on chromosome 20… 
• The posterior pituitary gland secretes : 
• AVP secretion is regulated primarily by the “effective” osmotic pressure of 
body fluids…  
 
• This control is mediated by specialized hypothalamic cells known as 
osmoreceptors, which are extremely sensitive to small changes in the 
plasma concentration of sodium and its anions but normally are insensitive 
to other solutes such as urea and glucose...  
 
• It is cleared irreversibly with a half-life (t 1/2) of 10–30 min and most AVP 
clearance is due to degradation in the liver and kidneys… 
 
• During pregnancy, the metabolic clearance of AVP is increased three to four 
fold due to placental production of an N-terminal peptidase. 
 
 
• ADH binds to receptors on the renal tubule, increasing the water 
permeability of the luminal membrane of the collecting duct epithelium… 
• This antidiuretic effect 
is mediated via a G 
protein–coupled V2 
receptor that increases 
intracellular c-AMP, 
thereby inducing 
translocation of 
aquaporin 2 water 
channels (AQP 2) into 
the apical membrane 
…  
• ADH also binds to peripheral arteriolar receptors (V1), causing 
vasoconstriction and resultant increase in blood pressure…  
 
• ADH also causes bradycardia and the inhibition of sympathetic nerve activity... 
(a counter-effect to the hypertensive effect of ADH ) 
DIABETES INSIPIDUS 
• DI can be: 
 
 Neurogenic (central) 
 
 Nephrogenic 
 Gestational - primary deficiency of plasma AVP can result from 
increased metabolism by an N-terminal amino-peptidase produced by 
the placenta… 
• Diabetes insipidus (DI) is characterized excretion of large volumes of dilute 
urine and caused by low secretion or action of ADH… 
Causes of Diabetes insipidus 

Diagnosis… 
• The primary test used to differentiate the causes of polyuria is the water 
deprivation test. 
 
• In diabetes insipidus (central or nephrogenic), inappropriate diuresis results 
in a urine osmolarity that is less than that of plasma osmolarity….  
 
• If DI is confirmed, basal plasma arginine vasopressin (AVP) should be 
measured on unrestricted fluid intake…  
• Regardless of the cause, patients are polyuric (50 mL/kg per day), secreting 
large volumes of dilute urine and this causes cellular and extracellular 
dehydration, stimulating thirst …  

• If MRI and/or AVP assays with the requisite sensitivity and specificity 
are unavailable and a fluid deprivation test is impractical or undesirable, 
a third way to differentiate between pituitary DI, nephrogenic DI, and 
primary polydipsia is a trial of desmopressin therapy...  
 
• Such a trial should be conducted with very close monitoring  of serum sodium 
as well as urine output, preferably in hospital, because desmopressin will 
produce hyponatremia in 8–24 h if the patient has primary polydipsia… 
TREATMENT… 
• DDAVP acts selectively at V2 receptors to increase urine concentration 
and decrease urine flow … 
 
• DDAVP can be given by IV or SC injection, nasal inhalation, or orally by 
means of a tablet of melt. 
 
• Among adults, they usually range from 1–2 μg qd or bid by injection,       
10–20 μg bid or tid by nasal spray, or 100–400 μg bid or tid orally…  
 
• Primary polydipsia cannot be treated safely with DDAVP or any other 
antidiuretic drug because eliminating the polyuria does not eliminate the 
urge to drink (water intoxication…) 
• Nephrogenic DI are not affected by treatment with standard doses of 
DDAVP, but if resistance is partial, it may be overcome by ten-fold higher 
doses… 
 
• However, treatment with conventional doses of a thiazide diuretic and/ or 
amiloride in conjunction with a low-sodium diet and a prostaglandin 
synthesis inhibitor (Indomethacin) usually reduces the polyuria and 
polydipsia by 30–70%...  
 

